These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 19851106)

  • 1. Obesity hypertension: the emerging role of leptin in renal and cardiovascular dyshomeostasis.
    Kshatriya S; Reams GP; Spear RM; Freeman RH; Dietz JR; Villarreal D
    Curr Opin Nephrol Hypertens; 2010 Jan; 19(1):72-8. PubMed ID: 19851106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity hypertension: pathophysiological role of leptin in neuroendocrine dysregulation.
    Go O; Freeman RH; Reams GP; Spear R; Liu K; Villarreal D
    Am J Med Sci; 2014 Jun; 347(6):485-9. PubMed ID: 23426087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of adipose tissue for cardiovascular-renal regulation in health and disease.
    Engeli S; Sharma AM
    Horm Metab Res; 2000; 32(11-12):485-99. PubMed ID: 11246814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity-hypertension: emerging concepts in pathophysiology and treatment.
    Mathew B; Patel SB; Reams GP; Freeman RH; Spear RM; Villarreal D
    Am J Med Sci; 2007 Jul; 334(1):23-30. PubMed ID: 17630587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin signaling and obesity: cardiovascular consequences.
    Yang R; Barouch LA
    Circ Res; 2007 Sep; 101(6):545-59. PubMed ID: 17872473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of leptin in blood pressure regulation and arterial hypertension.
    Bełtowski J
    J Hypertens; 2006 May; 24(5):789-801. PubMed ID: 16612235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of the physiology and pathophysiology of leptin with special emphasis on its role in the kidney.
    Nasrallah MP; Ziyadeh FN
    Semin Nephrol; 2013 Jan; 33(1):54-65. PubMed ID: 23374894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin: linking obesity, the metabolic syndrome, and cardiovascular disease.
    Patel SB; Reams GP; Spear RM; Freeman RH; Villarreal D
    Curr Hypertens Rep; 2008 Apr; 10(2):131-7. PubMed ID: 18474180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome.
    Correia ML; Rahmouni K
    Diabetes Obes Metab; 2006 Nov; 8(6):603-10. PubMed ID: 17026484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Leptin--adipose tissue hormone and its role in cardiovascular diseases].
    Racek-Król B
    Pol Merkur Lekarski; 2006 Jun; 20(120):713-6. PubMed ID: 17007277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptin in end stage renal disease (ESRD): a link between fat mass, bone and the cardiovascular system.
    Mallamaci F; Tripepi G; Zoccali C
    J Nephrol; 2005; 18(4):464-8. PubMed ID: 16245256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y and alpha-melanocyte-stimulating hormone: interaction in obesity and possible role in the development of hypertension.
    Baltatzi M; Hatzitolios A; Tziomalos K; Iliadis F; Zamboulis Ch
    Int J Clin Pract; 2008 Sep; 62(9):1432-40. PubMed ID: 18793378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms.
    Hall JE; do Carmo JM; da Silva AA; Wang Z; Hall ME
    Circ Res; 2015 Mar; 116(6):991-1006. PubMed ID: 25767285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of obesity-induced hypertension.
    Kotsis V; Stabouli S; Papakatsika S; Rizos Z; Parati G
    Hypertens Res; 2010 May; 33(5):386-93. PubMed ID: 20442753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The adipose tissue as an endocrine organ.
    Adamczak M; Wiecek A
    Semin Nephrol; 2013 Jan; 33(1):2-13. PubMed ID: 23374889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiological role of leptin in obesity-related hypertension.
    Aizawa-Abe M; Ogawa Y; Masuzaki H; Ebihara K; Satoh N; Iwai H; Matsuoka N; Hayashi T; Hosoda K; Inoue G; Yoshimasa Y; Nakao K
    J Clin Invest; 2000 May; 105(9):1243-52. PubMed ID: 10791999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging role of adipokines as mediators of cardiovascular function: physiologic and clinical perspectives.
    Gualillo O; González-Juanatey JR; Lago F
    Trends Cardiovasc Med; 2007 Nov; 17(8):275-83. PubMed ID: 18021938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin as a common link to obesity and hypertension.
    Mukherjee R; Villarreal D; Reams GP; Freeman RH; Tchoukina I; Spear RM
    Timely Top Med Cardiovasc Dis; 2006 Jan; 10():E1. PubMed ID: 16404481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipokines and the cardiovascular system: mechanisms mediating health and disease.
    Northcott JM; Yeganeh A; Taylor CG; Zahradka P; Wigle JT
    Can J Physiol Pharmacol; 2012 Aug; 90(8):1029-59. PubMed ID: 22646022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central and peripheral contributions to obesity-associated hypertension: impact of early overnourishment.
    Morris MJ; Velkoska E; Cole TJ
    Exp Physiol; 2005 Sep; 90(5):697-702. PubMed ID: 16105938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.